Growth failure in children with intractable epilepsy is not due to increased resting energy expenditure

A G Christina Bergqvist1, Jillian Trabulsi, Joan I Schall

  • 1Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. bergqvist@email.chop.edu

Insights

Children with intractable epilepsy (IE) have lower resting energy expenditure (REE) and growth status compared to healthy peers. Cerebral palsy (CP) significantly contributes to these differences in children with IE.

Area of Science:

  • Pediatric Neurology
  • Clinical Nutrition
  • Metabolic Research

Background:

  • Intractable epilepsy (IE) can impact a child's overall health and metabolic status.
  • Understanding resting energy expenditure (REE) is crucial for managing nutritional needs in children with chronic conditions.
  • Cerebral palsy (CP) is a common comorbidity in children with IE, potentially affecting their energy balance.

Purpose of the Study:

  • To compare the resting energy expenditure (REE) of children with intractable epilepsy (IE) to that of healthy children.
  • To identify factors, including cerebral palsy (CP), that influence REE patterns in children with IE.
  • To assess growth status and body composition in relation to REE in this population.

Main Methods:

  • Indirect calorimetry was used to measure REE in 25 children with IE and 75 healthy children.
  • Growth parameters (weight z-score, BMI z-score) and body composition (fat-free mass) were assessed.
  • Multiple regression analysis was employed to determine predictors of REE, including CP and energy intake.

Main Results:

  • Children with IE exhibited significantly lower predicted REE, weight z-scores, BMI z-scores, and fat-free mass compared to healthy controls.
  • In children with IE and CP, REE adjusted for body composition was significantly lower (-110 kcal/d).
  • Energy intake was a significant predictor of REE in children with IE.

Conclusions:

  • Cerebral palsy (CP) is a major factor contributing to the reduced growth status and lower REE observed in children with intractable epilepsy (IE).
  • These findings highlight the complex interplay between neurological conditions, comorbidities, and metabolic regulation in pediatric populations.
  • Optimizing nutritional support and considering comorbidities like CP are essential for managing children with IE.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Overview of Metabolism01:40

Overview of Metabolism

Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.